About the journal
Current Pharmaceutical Design is a journal published by Bentham Science Publishers in Netherlands. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Bentham Science Publishers
- ISSN
- 1381-6128 · 1873-4286
- Country
- Netherlands
- Access
- Not open access / not declared
- Official website
- http://www.bentham.org/cpd/index.htm
Index listings
- MEDLINE · 1998-01-01
- PUBMED · 2011-12-01
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 82 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
11577
Last recorded publication year
2026
h-index
207
i10-index
7285
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- Portico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 62%
- ORCID iDs in current deposits
- 44%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9602487
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Computational Drug Discovery Methods
- Computational Drug Discovery Methods
- Nanoparticle-Based Drug Delivery
- Nanoparticle-Based Drug Delivery
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Advanced Drug Delivery Systems
- Advanced Drug Delivery Systems
Show all subjects (50)
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Lipoproteins and Cardiovascular Health
- Lipoproteins and Cardiovascular Health
- Tryptophan and brain disorders
- Tryptophan and brain disorders
- Synthesis and biological activity
- Receptor Mechanisms and Signaling
- Synthesis and biological activity
- Cholinesterase and Neurodegenerative Diseases
- Receptor Mechanisms and Signaling
- Cholinesterase and Neurodegenerative Diseases
- Neuroscience and Neuropharmacology Research
- Neuroscience and Neuropharmacology Research
- Diet and metabolism studies
- Diet and metabolism studies
- Advancements in Transdermal Drug Delivery
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Inflammatory mediators and NSAID effects
- Inflammatory mediators and NSAID effects
- Advancements in Transdermal Drug Delivery
- Neuropeptides and Animal Physiology
- Neuropeptides and Animal Physiology
- Chemical Synthesis and Analysis
- Chemical Synthesis and Analysis
- Atherosclerosis and Cardiovascular Diseases
- Atherosclerosis and Cardiovascular Diseases
- HIV/AIDS drug development and treatment
- HIV/AIDS drug development and treatment
- Antiplatelet Therapy and Cardiovascular Diseases
- Alzheimer's disease research and treatments
- Alzheimer's disease research and treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Drug Solubulity and Delivery Systems
- Radiopharmaceutical Chemistry and Applications
- Radiopharmaceutical Chemistry and Applications
- Eicosanoids and Hypertension Pharmacology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ